Document Detail


Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
MedLine Citation:
PMID:  2874765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We measured the concentration of gamma-aminobutyric acid (GABA), glutamic acid, and o-phosphoethanolamine in autopsied brain of 9 patients who died with idiopathic Parkinson's disease and 10 control subjects. In the control striatum GABA showed an uneven rostrocaudal distribution pattern with rostral subdivisions containing about 40 to 50% higher levels. When compared with controls, GABA concentrations in Parkinson's disease striatum were generally elevated. The GABA elevation was most pronounced in the caudal subdivision of the putamen; this striatal subdivision also showed the most severe dopamine loss. We observed in the caudal putamen a significant negative correlation between the (elevated) GABA and (reduced) dopamine levels (the latter expressed as the sum of dopamine plus 3-methoxytyramine). Milder nonsignificant elevations of GABA levels were observed in intermediate and rostral putamen followed by the caudate head subdivisions. GABA levels were normal in all extrastriatal brain areas examined. Striatal glutamic acid levels were markedly elevated in 3 of the 9 patients with Parkinson's disease. We suggest that the altered GABA metabolism in the striatum, especially the putamen, is consequent to the nigrostriatal deficiency in this disorder. This secondary change in striatal GABA function is likely to contribute to the basal ganglia dysfunction produced by the striatal dopamine loss and thus may be related to certain aspects of parkinsonian symptomatology.
Authors:
S J Kish; A Rajput; J Gilbert; B Rozdilsky; L J Chang; K Shannak; O Hornykiewicz
Related Documents :
2860945 - Relation between consumption of alcohol and fatty acids esterifying serum cholesterol i...
3958715 - Amino acid neurotransmitters in the cns: properties of diaminobutyric acid transport.
17988865 - Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of gab...
4146575 - Inhibition by gamma-hydroxybutyrate of chlorpromazine-induced increase in homovanillic ...
18366605 - Supervised learning method for the prediction of subcellular localization of proteins u...
2191595 - Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoc...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of neurology     Volume:  20     ISSN:  0364-5134     ISO Abbreviation:  Ann. Neurol.     Publication Date:  1986 Jul 
Date Detail:
Created Date:  1986-09-17     Completed Date:  1986-09-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  26-31     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Chemistry*
Corpus Striatum / enzymology
Dopamine / analogs & derivatives,  analysis*
Ethanolamines / analysis
Glutamate Decarboxylase / metabolism
Glutamates / analysis
Glutamic Acid
Humans
Parkinson Disease / etiology,  metabolism*
gamma-Aminobutyric Acid / analysis*
Chemical
Reg. No./Substance:
0/Ethanolamines; 0/Glutamates; 1071-23-4/phosphorylethanolamine; 554-52-9/3-methoxytyramine; 56-12-2/gamma-Aminobutyric Acid; 56-86-0/Glutamic Acid; EC 4.1.1.15/Glutamate Decarboxylase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis of left-sided regurgitant murmurs by transient arterial occlusion: a new maneuver using bl...
Next Document:  Discontinuous transcription and antigenic variation in trypanosomes.